🌅 Pre-Market Briefing — 2026-06-24 · 06:19 PDT

Apple is mentioned only in megacap/AI-spend roundups (Alphabet's Dow addition, $2.7T Mag7 drawdown) with a flat +0.4% move and no Apple-specific catalyst.

AbbVie's only item is a BOTOX Cosmetic marketing program; coverage references its prior Apogee acquisition in biotech-M&A roundups, with an essentially flat move and no fresh catalyst.

Alamos Gold fell after BMO cut its target to C$73 citing two seismic events at Young-Davidson and reduced 2026 mining rates; the Finviz headline is a generic gold-sector note.

AMD appears only in semiconductor-selloff coverage (Cerebras margin warning, AI-trade rotation) with a flat +0.2% move and no AMD-specific catalyst.

Micron's news is pre-earnings positioning ahead of its after-the-bell Q3 print; the +2.8% gap is below the EP threshold and reflects anticipation, not a reported result.

Nvidia is referenced in dollar/macro and AI-build-out roundups with a flat -0.3% move and no company-specific catalyst.

Palantir's coverage is technical-breakdown commentary (one-year low, broken chart) within a software-weakness theme, a -2.5% move with no positive catalyst.

Supermicro's items are a StorMagic edge collaboration and an Odine partnership to build data centers in Türkiye, minor partner/integration deals with no disclosed value, on a flat +0.4% move.

Sunrun/Tesla/Renew Home announced a VPP teaming for up to 16GW to serve data centers, but it's a capacity-framework headline with no contract value or revenue terms, and the most company-specific article is actually a StockStory sell piece on RUN's margin losses and cash burn.

MiniMed launched Instinct sensors in Europe, an incremental product line-extension explicitly framed as 'same proven outcomes,' and RVOL of 0.00 against a +13% gap signals no real volume confirmation.

The only SITE-specific item is hosting a 2026 Investor Day, while recent news cites a Q1 earnings miss and net loss; the fetched article is about RenoWorks, not SiteOne.

FIGS only announced participation in an Oppenheimer conference with RVOL 0.01, no company-specific catalyst, and the inflated EPSqq sits against InstOwn ~91%.

Benchmark was named Ouster's manufacturing partner to scale Rev8 color lidar (and HPE's manufacturing partner of the year), a real customer win for the contract-manufacturer but with no disclosed volume or revenue terms and BHE captures only contract-manufacturing margin.

DT120 ODT hit all Phase 3 Emerge endpoints earlier in the week, but today's move accompanies pricing of an upsized $700M follow-on at $34, an immediately dilutive raise overhanging the post-data run.

KB Home's Q2 EPS of $0.43 merely met estimates on revenue down ~23% YoY, with sequential margin and backlog improvement but no upside surprise or raised guidance.

Telix's catalyst is a June 2 MoU (non-binding) with United Imaging for theranostics research plus an educational webinar, neither carrying financial terms or near-term revenue.

ICON rose on a 2026 outlook, buyback and governance shake-up, but it carries an open Audit Committee revenue-recognition investigation (2023-2025) with an anticipated <2%/year restatement still overhanging.

Maryland is acquiring the Preakness IP rights from Churchill Downs, a small asset divestiture immaterial to a $6.4B company, with RVOL 0.01 and the fetched article a CHDN-vs-TTWO value comparison.

Enerflex only published a 2026 Investor Update presentation with RVOL 0.00; coverage is Zacks momentum/rank commentary, no transformational catalyst.

Janus Living (recent Healthpeak IPO spinout) only announced Q2 earnings call dates; the article centers on parent Healthpeak's raised FFOA guidance, not JAN itself.

The headline is a macro labor survey, not RHI-specific; the article is Korn/Ferry's earnings beat, with no Robert Half catalyst despite the 24.6% short float.

Amer Sports is cited within a footwear-earnings-season roundup noting Arc'teryx/Salomon acceleration, a sector-theme mention with no AS-specific binding catalyst and only a +4.3% move.

Spyre released SPY002 anti-TL1A Part A induction data framed as 'potential best-in-class,' yet shares fell ~14%, indicating the readout disappointed versus expectations on this binary clinical event.

The only Hub Group item is an interim CFO's $125K/month pay amid downbeat coverage flagging ~9% annual sales declines; the move is a -10% decline with RVOL 0.01, no positive catalyst.

Cerebras' first post-IPO earnings guided 2026 adjusted gross margins to 38-41% versus 47% in Q1, a margin warning sending shares down ~14% despite triple-digit revenue growth and only ~4% institutional ownership.

Aeroméxico only announced a Q2 results webcast with RVOL 0.00; the move is a -9% decline with no company-specific catalyst in the news.

Houlihan Lokey's only item is a senior hire expanding GP-led secondaries into real estate, a minor personnel move, with shares down ~7% on RVOL 0.00.

AngloGold's headline is an unrelated Tanzania junior project; AU-specific news is analyst-rating commentary, and the -7.5% move tracks a gold-sector pullback rather than a company catalyst.

The headline concerns the Skaergaard PGM project (different entity); SBSW's own news is older debt-tender and nuclear-medicine JV items, and the -7% move reflects PGM/sector action, not a fresh catalyst.

Gold Fields fell on a Bloomberg report that Ghana is considering shifting control of Tarkwa (its largest mine, leases expiring April 2027) to local businesses, a binary regulatory/political risk to a key asset; the Finviz headline about a 'Barry Deposit' is a different company.

CCXI is the shell tied to Agility Robotics' announced $2.5B Michael Klein-backed SPAC deal to go public, a transformational reverse-merger but a structurally volatile de-SPAC with extreme RVOL (~3446) and no article body retrieved.

Wendy's named Steve Cirulis CFO/CSO, but the +31% move is driven by a retail-fueled short squeeze (short interest ~26-30%, RVOL 56.7, top Reddit/Stocktwits mentions) rather than a fundamental catalyst.

Absci reported positive interim Phase 1 safety/tolerability data for ABS-201 in hair loss with no serious adverse events, early-stage de-risking (not efficacy) amplified by a 24% short float and RVOL 17.7.

FuelCell Energy signed a framework with Fit Energy for up to 380MW of data-center power, but only an initial 30MW (with a deposit) is committed this year and the balance is milestone-based, riding the AI-power theme.

InMode confirmed receipt of an unsolicited acquisition proposal, an early M&A approach with no price, terms, or board decision disclosed, leaving the outcome binary.